See All Slides - tctmd.com

Slides

Presentation TCT 2014

Current Status of Acute Stroke Therapy: Trials, Tribulations, and Practical Issues

Presenter: Leo Nelson Hopkins, Sriram S. Iyer, Zvonimir Krajcer, Adnan Siddiqui

September 13, 2014

Presentation TCT 2014

Setting the Stage: Most Important Mitral Regurgitation Studies and Events of the Last 12 Months

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Gregg W. Stone

September 13, 2014

Presentation TCT 2014

Randomized vs Observational Studies: Strengths and Weaknesses

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen

September 13, 2014

Presentation TCT 2014

Technique Strategy Selection: A Critical Review of International Consensus Group Position Papers

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Sahil A. Parikh

September 13, 2014

Presentation TCT 2014

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Sanjay Kaul

September 13, 2014

Presentation TCT 2014

Case #2: Saphenous Vein Graft PCI (NYP)

Presenter: Regina Deible, Julie Logan, John R. Zimmerman

September 13, 2014

Presentation TCT 2014

Antegrade Guidewires: Technology and Selection

Presenter: J. Aaron Grantham, Masahisa Yamane, Mauro Carlino, Masahiko Ochiai

September 13, 2014

Presentation TCT 2014

TCT 65: The Efficacy and Safety of Mechanical Hemodynamic Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention With or Without Cardiogenic Shock: Bayesian Approach Network Meta-analysis of 13 Randomized Controlled Trials

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Jonghanne Park

September 13, 2014

Presentation TCT 2014

Subclavian and Innominate Intervention: Not as Easy as it Looks

Presenter: Leo Nelson Hopkins, Sriram S. Iyer, Zvonimir Krajcer, Douglas E. Drachman

September 13, 2014

Presentation TCT 2014

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Rami Tzafriri

September 13, 2014

Advertisement

Slides

Current Status of Acute Stroke Therapy: Trials, Tribulations, and Practical Issues

Setting the Stage: Most Important Mitral Regurgitation Studies and Events of the Last 12 Months

Randomized vs Observational Studies: Strengths and Weaknesses

Technique Strategy Selection: A Critical Review of International Consensus Group Position Papers

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Case #2: Saphenous Vein Graft PCI (NYP)

Antegrade Guidewires: Technology and Selection

TCT 65: The Efficacy and Safety of Mechanical Hemodynamic Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention With or Without Cardiogenic Shock: Bayesian Approach Network Meta-analysis of 13 Randomized Controlled Trials

Subclavian and Innominate Intervention: Not as Easy as it Looks

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content